» Articles » PMID: 23718816

A Novel Model of Adenine-induced Tubulointerstitial Nephropathy in Mice

Overview
Journal BMC Nephrol
Publisher Biomed Central
Specialty Nephrology
Date 2013 May 31
PMID 23718816
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In vivo models of uremia are important tools to study numerous aspects of acute and chronic kidney disease. Mouse models are pivotal because most genetically engineered animal models are mice, which allow dissecting the impact of selected target genes in renal failure. Adenine-based protocols to induce renal failure are available in rats, but have not been adapted in mice due to their reluctance to consume adenine. In the current paper we developed a novel method for induction of renal failure through dietary delivery of adenine mixed in a casein-based diet.

Results: After an induction phase, a stable model of renal impairment was obtained (target urea range 80-100 mg/dL), mimicking several aspects of chronic kidney disease - mineral and bone disorder including secondary hyperparathyroidism, bone abnormalities and pathological elevation of FGF23. No deaths occurred and the level of uremia was adaptable through adjustments of the adenine content, providing significant advantages compared to existing models. In an 8-week proof-of-concept study, renal histology showed mainly a tubulointerstitial damage with infiltrating leukocytes, interstitial edema and widening of the Bownman's space. Fibrosis was present in most animals as defined by histology and gene expression changes of fibrosis markers. Parathyroid cell proliferation was markedly increased but without signs of glandular hypertrophy. Skeletal histology showed increased trabecular bone and bone marrow adiposity whereas bone biomarkers (CTX and PINP) suggested higher bone formation, but surprisingly, lower bone resorption and perturbations in mineral metabolism.

Conclusions: We present a novel, non-surgical method for induction of renal failure in mice. This is an important complement to existing uremic models for pathophysiological studies in acute and chronic kidney disease, especially in terms of tubulointerstitial lesions.

Citing Articles

The Many Faces of Protease-Activated Receptor 2 in Kidney Injury.

Oe Y, Tanaka T, Takahashi N Biomedicines. 2025; 13(2).

PMID: 40002827 PMC: 11852827. DOI: 10.3390/biomedicines13020414.


Targeted Polymer-Peptide Conjugates for E-Selectin Blockade in Renal Injury.

Milosevic N, Rutter M, Ventura Y, Feinshtein V, David A Pharmaceutics. 2025; 17(1).

PMID: 39861730 PMC: 11768228. DOI: 10.3390/pharmaceutics17010082.


Transgenic augmentation of erythroferrone in mice ameliorates anemia in adenine-induced chronic kidney disease.

Czaya B, Olivera J, Zhang M, Lundin A, Castro C, Jung G bioRxiv. 2024; .

PMID: 39713359 PMC: 11661078. DOI: 10.1101/2024.12.06.627111.


The roles of mTORC1 in parathyroid gland function in chronic kidney disease-induced secondary hyperparathyroidism: Evidence from male genetic mouse models and clinical data.

Khalaily N, Hassan A, Khream Y, Naveh-Many T, Ben-Dov I FASEB J. 2024; 38(22):e70184.

PMID: 39570083 PMC: 11580712. DOI: 10.1096/fj.202401547RR.


Renal Proximal Tubule Cell-Specific Megalin Deletion Does Not Affect Atherosclerosis But Induces Tubulointerstitial Nephritis in Mice Fed a Western Diet.

Amioka N, Franklin M, Kukida M, Zhu L, Moorleghen J, Howatt D Arterioscler Thromb Vasc Biol. 2024; 45(1):74-89.

PMID: 39569521 PMC: 11668626. DOI: 10.1161/ATVBAHA.124.321366.


References
1.
Yang H, Zuo Y, Fogo A . Models of chronic kidney disease. Drug Discov Today Dis Models. 2011; 7(1-2):13-19. PMC: 3030258. DOI: 10.1016/j.ddmod.2010.08.002. View

2.
Wolf M . Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol. 2010; 21(9):1427-35. DOI: 10.1681/ASN.2009121293. View

3.
Gurley S, Mach C, Stegbauer J, Yang J, Snow K, Hu A . Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. Am J Physiol Renal Physiol. 2010; 298(3):F788-95. PMC: 2838602. DOI: 10.1152/ajprenal.90515.2008. View

4.
Manucha W, Oliveros L, Carrizo L, Seltzer A, Valles P . Losartan modulation on NOS isoforms and COX-2 expression in early renal fibrogenesis in unilateral obstruction. Kidney Int. 2004; 65(6):2091-107. DOI: 10.1111/j.1523-1755.2004.00643.x. View

5.
Pimentel Jr J, Sundell C, Wang S, Kopp J, Montero A, MARTINEZ-MALDONADO M . Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy. Kidney Int. 1995; 48(4):1233-46. DOI: 10.1038/ki.1995.407. View